CVS Stock: Price, Earnings History and SEC Filings
CVS Health Corporation (CVS) last traded at $90.25, down 0.09% on the latest session and up 5.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.58 against an analyst estimate of $1.87, a beat of 38.0%.
$90.25 -0.09%
1 month+5.32%
52-week high$110.68
52-week low$69.51
Volume8.19M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CVS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $2.58 | $1.87 | +37.97% |
| Mar 2026 | May 6, 2026 | $2.57 | $2.21 | +16.29% |
| Dec 2025 | Feb 10, 2026 | $1.09 | $0.99 | +10.10% |
| Sep 2025 | Oct 29, 2025 | $1.60 | $1.36 | +17.65% |
CVS beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for CVS
SEC filing data is not available right now. You can search for CVS on SEC EDGAR.
CVS news
- After He Returned From The Pacific Theater, A World War II Vet Bought $1,000 Of Walgreen Stock. 7 Decades Later, Russ Gremel’s $1,000 Investment Had Grown To Over $2 MillionNov 1, 2026 · 247wallst.com
- Mark Cuban Says Public Companies Found They Were ‘Ripped Off’ On Healthcare But Won’t Say So On Earnings CallsNov 1, 2026 · stocktwits.com
- CVS Health (CVS) Could Be 27% Undervalued As Earnings Focus SharpensOct 31, 2026 · finance.yahoo.com
- 1 value stock to own for decades and 2 we ignoreOct 30, 2026 · finance.yahoo.com
- BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%Oct 30, 2026 · tikr.com
- CVS Health Stock: Analyst Estimates & RatingsOct 30, 2026 · barchart.com
- CVS Health: How Education and Everyday Action Can Support Medication SafetyOct 30, 2026 · finance.yahoo.com
- Countdown to CVS Health (CVS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSOct 30, 2026 · finance.yahoo.com
About CVS Health Corporation
CVS Health Corporation (CVS) is a US-listed public company on NYSE.